Medicare Enrolled
Dr. Michael McClelland, MD
Urology Physician · Austin, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McClelland from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McClelland?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McClelland
Dr. Michael McClelland is an urology physician in Austin, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. McClelland performed 3,753 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McClelland received a total of $5,706 from 53 pharmaceutical and/or device companies across 303 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McClelland is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 32% volume in TX
$5,706 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,753
Medicare services
Top 32% in TX for urology physician
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
860 | $93 | $249 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
680 | $2 | $7 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
551 | $48 | $77 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
486 | $8 | $44 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
314 | $8 | $15 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
182 | $190 | $477 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
181 | $37 | $77 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
150 | $3 | $10 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
132 | $0 | $3 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $109 | $380 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $139 | $336 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $68 | $168 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $170 | $508 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $116 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $58 | $167 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
12 | $46 | $194 |
| Prostate tissue destruction using radiofrequency heated water vapor A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland. |
12 | $1,394 | $4,379 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,706
Total received (2018-2024)
Avg $815/year across 7 years
Top 34% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
303
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$894
2023
$683
2022
$574
2021
$904
2020
$550
2019
$821
2018
$1,280
Payments by company (2024)
Janssen Biotech, Inc.
$178
Sumitomo Pharma America, Inc.
$137
ABBVIE INC.
$128
Olympus America Inc.
$85
Endo USA, Inc.
$66
UROGEN PHARMA, INC.
$44
PFIZER INC.
$39
Smith+Nephew, Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$35
PROCEPT BioRobotics Corporation
$34
AstraZeneca Pharmaceuticals LP
$28
Merck Sharp & Dohme LLC
$26
Boston Scientific Corporation
$21
Teleflex LLC
$20
Provepharm Inc.
$16
Top 3 companies account for 49.5% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$720
PFIZER INC.
$433
Janssen Biotech, Inc.
$410
ABBVIE INC.
$405
Sumitomo Pharma America, Inc.
$332
Endo Pharmaceuticals Inc.
$297
Boston Scientific Corporation
$205
AbbVie, Inc.
$181
Allergan Inc.
$172
PROCEPT BioRobotics Corporation
$157
Blue Earth Diagnostics Limited
$155
Clarus Therapeutics Inc.
$129
BOSTON SCIENTIFIC CORPORATION
$122
NeoTract Inc.
$117
Olympus America Inc.
$105
Myovant Sciences Inc.
$95
Dendreon Pharmaceuticals LLC
$95
ConvaTec Inc.
$93
Axonics, Inc.
$81
Merck Sharp & Dohme Corporation
$73
180 Medical, Inc.
$71
Allergan, Inc.
$67
NxThera, Inc.
$67
Endo USA, Inc.
$66
Rochester Medical Corporation
$64
AbbVie Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$57
Antares Pharma, Inc.
$57
Medtronic, Inc.
$57
Teleflex LLC
$52
AstraZeneca Pharmaceuticals LP
$50
Merck Sharp & Dohme LLC
$50
Retrophin, Inc.
$50
C. R. BARD, INC. & SUBSIDIARIES
$47
UROGEN PHARMA, INC.
$44
Travere Therapeutics, Inc.
$42
Alexion Pharmaceuticals, Inc.
$40
Foundation Medicine, Inc.
$38
Smith+Nephew, Inc.
$38
UROVANT SCIENCES INC
$35
Kowa Pharmaceuticals America, Inc.
$31
Ferring Pharmaceuticals Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$26
C. R. Bard, Inc. & Subsidiaries
$25
Progenics Pharmaceuticals, Inc.
$25
Myriad Genetic Laboratories, Inc.
$24
Aytu BioScience, Inc
$24
Telix Pharmaceuticals
$23
Supernus Pharmaceuticals, Inc.
$19
Provepharm Inc.
$16
Avadel Specialty Pharmaceuticals, LLC
$15
Amgen Inc.
$13
Baxter Healthcare
$11
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AQUABEAM SYSTEM · AVEED · AVYCAZ · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BLUDIGO · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · CATHETER · EDEX · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL - BPH · GENERAL BPH · GENTLECATH · General - BPH · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · PROVENGE · PYLARIFY · Prolaris · Rezum · Rezum Generator · SEGLENTIS · STRAVIX PL · SUTENT · TISSEEL · TLANDO · TOVIAZ · Thiola · ULTOMIRIS · UROLIFT · Ultomiris · UroLift · UroLift System · VIAGRA · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
69
County median income
$97,169
Nearest hospital to ZIP centroid (approximate)
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McClelland is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McClelland experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McClelland performed 860 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McClelland receive payments from pharmaceutical companies?
Yes. Dr. McClelland received a total of $5,706 from 53 companies across 303 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McClelland's costs compare to other urology physicians in Austin?
Dr. McClelland's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McClelland) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Austin
Browse urology physicians in Austin ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology